Skip to content

Effect of Shenqi Shengmian Decoction on Postoperative First Recurrence in Bladder Cancer Patients (Spleen Deficiency with Dampness-Heat and Blood Stasis Syndrome): A Retrospective Cohort Study

Effect of Shenqi Shengmian Decoction on Postoperative First Recurrence in Bladder Cancer Patients (Spleen Deficiency with Dampness-Heat and Blood Stasis Syndrome): A Retrospective Cohort Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2025001923
Enrollment
Unknown
Registered
2025-10-15
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Interventions

Exposome Group:Taking Shenqi Shengmian Decoction
Non-Exposed Group:Not Taking Shenqi Shengmian Decoction

Sponsors

Hubei Provincial Hospital of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1: Age =18 years. 2: Met the Western diagnostic criteria for bladder cancer and had undergone surgical treatment. 3: Diagnosed with dampness-heat-blood stasis syndrome based on Traditional Chinese Medicine (TCM) differentiation. 4: Complete medical records available with consent for clinical data usage.

Exclusion criteria

Exclusion criteria: 1: Presence of other malignant tumors (secondary malignancies). 2: Severe comorbidities significantly affecting survival (e.g. major cardiovascular/cerebrovascular diseases hepatic/renal failure) excluding bladder cancer itself. 3: Patients with immune system disorders (e.g. autoimmune diseases immunodeficiency). 4: Current enrollment in other clinical trials or use of confounding medications. 5: Loss to follow-up rate >30%.

Design outcomes

Primary

MeasureTime frame
Pathological examination findings;

Secondary

MeasureTime frame
recurrence-free survival;Blood Analysis;Hepatic and Renal Function;

Countries

China

Contacts

Public ContactZhou Jie

Hubei Provincial Hospital of Traditional Chinese Medicine

zhoujieuser@163.com18571727602

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026